Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2657-2023Class II

Restore Clinician Programmer Application Software, model number A71100, used with the Restore Neurostimulators

Medtronic Neuromodulation / initiated 2020-07-17 / Terminated / root cause: software

Medtronic Neuromodulation began a recall of Restore Clinician Programmer Application Software, model number A71100, used with the Restore Neurostimulators on . FDA classified it as Class II and gives the reason as "The original version of the A71100 Restore Clinician Programmer Application has been identified to have a compatibility issue with some legacy clinician programmer software resulting in the programmer having an...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-2657-2023
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic Neuromodulation
Product
Restore Clinician Programmer Application Software, model number A71100, used with the Restore Neurostimulators.
Product code
LGW Stimulator, Spinal-Cord, Totally Implanted For Pain Relief
Reason for recall
The original version of the A71100 Restore Clinician Programmer Application has been identified to have a compatibility issue with some legacy clinician programmer software resulting in the programmer having an inability to establish communication with the implanted neurostimulators.
Root cause tag
software
FDA root cause
Software design
Action
Letters dated July 2020 and flagged as "URGENT: MEDICAL DEVICE CORRECTION RESTORE CLINICIAN PROGRAMMER APPLICATION SOFTWARE UPDATE Model A71100" were issued via USPS Priority First Class Mail on 7/17/2020. The letter provided an issue summary and informed the consignee the updated version of the A71100 application was now available for download and installation for resolving the issue. The consignee was to follow the instructions provided with the letter to update the application and if assistance was needed, contact information was provided for the Technical Services team support. Once the required update is made, the action will be tracked through the firm's mobile software deployment systems and no additional reply was needed from the consignee. The letter also explained patient risk, how to identify the issue, and conditions resulting in the issue. The letter was to be shared as appropriate with those in the consignee's organization who require the information.
Quantity in commerce
2,408 devices
Distribution
Worldwide distribution - US Nationwide (there was government and military distribution) and the countries of Australia and Singapore.
Product codes and lots
Version 1.0.4232, UDI-DI 00763000273668.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2657-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2657-2023Class IITerminatedVoluntary: Firm initiated